RCKT - Rocket Pharmaceuticals GAAP EPS of -$0.66 beats by $0.01
2024-05-06 16:42:31 ET
More on Rocket Pharmaceuticals
- Rocket Pharmaceuticals: Cautiously Optimistic (Rating Upgrade)
- Rocket Pharmaceuticals: Multiple Regulatory Submissions Make It A Must Watch
- Rocket Pharmaceuticals' Promising Path In Gene Therapy
- Rocket Pharma gains as EU accepts gene therapy for review
- Rocket Pharmaceuticals GAAP EPS of -$0.64 beats by $0.14